Results 141 to 150 of about 554,589 (315)
Effect of Tamoxifen on the Management of Dopamine Agonist-Resistant Prolactinomas: A Systematic Review. [PDF]
Cureus, 2023 Bazuhair T, Aleid B, Almalki M.
europepmc +1 more source
Movement Disorders, EarlyView.Abstract Objective To update evidence‐based medicine recommendations for treating motor fluctuations of Parkinson's disease (PD). Background The International Parkinson and Movement Disorder Society (MDS) Evidence Based Medicine in Movement Disorders Committee recommendations for the treatments of PD were first published in 2002 and regularly updated ...
Rob M.A. de Bie +21 more
wiley +1 more source
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist. [PDF]
Case Rep Dermatol, 2022 Talty R +4 more
europepmc +1 more source
Movement Disorders, EarlyView.Abstract Background Antidopaminergic medications (ADM) are often used for symptom management of Huntington's disease (HD). Evidence from past research suggests that ADMs are associated with worse clinical outcomes in HD, but their impact on various domains remains underexplored.
Michal Geva +5 more
wiley +1 more source
Preoperative medical treatments and surgical approaches for acromegaly: A systematic review
Clinical Endocrinology, Volume 98, Issue 1, Page 14-31, January 2023., 2023 Abstract Objective Acromegaly is a condition characterized by an overproduction of growth hormone which infers high morbidity and mortality if left untreated. The objective of this review is to analyse and appraise the current evidence for the generalized use of preoperative medications and the various surgical approaches as described in the literature.
Christos Papaioannou, Maralyn Druce
wiley +1 more source
Lack of Discrimination by Agonists for D2 and D3 Dopamine Receptors [PDF]
, 1995 Kevin D. Burris +5 more
openalex +1 more source
Movement Disorders, EarlyView.Abstract Background Subthalamic beta oscillations are a biomarker for bradykinesia and rigidity in Parkinson's disease (PD), incorporated as a feedback signal in adaptive deep brain stimulation with potential for guiding electrode contact selection.
Jennifer K. Behnke +13 more
wiley +1 more source
Dopaminergic Regulation of Progesterone Receptors: Brain D5 Dopamine Receptors Mediate Induction of Lordosis by D1-Like Agonists in Rats [PDF]
, 1996 Ede Marie Apostolakis +6 more
openalex +1 more source
Movement Disorders, EarlyView.Abstract Background Levodopa‐induced dyskinesia (LID) in Parkinson's disease (PD) is associated with ‘false neurotransmitter’ release of dopamine from serotonin (5‐HT) neurons. NLX‐112 is a first‐in‐class, highly selective 5‐HT1A receptor agonist which counteracts LIDs in experimental PD models.
Per Svenningsson +13 more
wiley +1 more source